A role for RUNX3 in inflammation-induced expression of IL23A in gastric epithelial cells

Cell Reports

Volumn 8, Issue 1, 2014, Pages 50-58

  Hor, Yit Teng ^a,b   Voon, Dominic Chih Cheng ^a   Koo, Jason Kin Wai ^a   Wang, Huajing ^a   Lau, Wen Min ^a   Ashktorab, Hassan ^c   Chan, Shing Leng ^a   Ito, Yoshiaki ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c HOWARD UNIVERSITY CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; PROTEIN TYROSINE PHOSPHATASE SHP 2; SMAD3 PROTEIN; TRANSCRIPTION FACTOR RUNX3; TUMOR NECROSIS FACTOR ALPHA; CASPASE RECRUITMENT DOMAIN PROTEIN 4; INTERLEUKIN 12P40; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; IL23A PROTEIN, HUMAN; NOD1 PROTEIN, HUMAN; RUNX3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER INHIBITION; CHROMATIN IMMUNOPRECIPITATION; CYTOKINE RELEASE; EPITHELIUM CELL; EXPRESSION VECTOR; GASTRIC CANCER CELL LINE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STOMACH EPITHELIUM; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; CONTROLLED STUDY; GENE REGULATORY NETWORK; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; CELL LINE; GASTRIC MUCOSA; GENETICS; METABOLISM; MICROBIOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

HELICOBACTER PYLORI;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; INTERLEUKIN-23 SUBUNIT P19; NF-KAPPA B; NOD1 SIGNALING ADAPTOR PROTEIN; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904431718     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.06.003     Document Type: Article

References (27)

1. Al-Sammak F., Kalinski T., Weinert S., Link A., Wex T., Malfertheiner P. Gastric epithelial expression of IL-12 cytokine family in Helicobacter pylori infection in human: is it head or tail of the coin?. PLoS ONE 2013, 8:e75192.
2. Baldwin A.S. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer. Immunol. Rev. 2012, 246:327-345.
3. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R., Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 1996, 93:14648-14653.
4. Chuang L.S., Ito K., Ito Y. RUNX family: regulation and diversification of roles through interacting proteins. Int. J. Cancer 2013, 132:1260-1271.
5. Ciccia F., Bombardieri M., Principato A., Giardina A., Tripodo C., Porcasi R., Peralta S., Franco V., Giardina E., Craxi A., et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 2009, 60:955-965.
6. Collins A., Littman D.R., Taniuchi I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat. Rev. Immunol. 2009, 9:106-115.
7. Fox J.G., Wang T.C. Inflammation, atrophy, and gastric cancer. J.Clin. Invest. 2007, 117:60-69.
8. Gebert B., Fischer W., Weiss E., Hoffmann R., Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003, 301:1099-1102.
9. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 2005, 5:521-531.
10. Ito K., Liu Q., Salto-Tellez M., Yano T., Tada K., Ida H., Huang C., Shah N., Inoue M., Rajnakova A., et al. RUNX3, a novel tumor suppressor, isfrequently inactivated in gastric cancer by protein mislocalization. Cancer Res. 2005, 65:7743-7750.
11. Ito K., Chuang L.S., Ito T., Chang T.L., Fukamachi H., Salto-Tellez M., Ito Y. Loss of Runx3 is a key event in inducing precancerous state ofthe stomach. Gastroenterology 2011, 140:1536-1546.e8.
12. Jobin C., Sartor R.B. The I kappa B/NF-kappa B system: a keydeterminant of mucosalinflammation and protection. Am. J. Physiol. Cell Physiol. 2000, 278:C451-C462.
13. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic Tcell population that induces autoimmune inflammation. J.Exp. Med. 2005, 201:233-240.
14. Levanon D., Negreanu V., Lotem J., Bone K.R., Brenner O., Leshkowitz D., Groner Y. Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation. Mol. Cell. Biol. 2014, 34:1158-1169.
15. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue Ki., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109:113-124.
16. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
17. Monack D.M., Mueller A., Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2004, 2:747-765.
18. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
19. Odenbreit S., Püls J., Sedlmaier B., Gerland E., Fischer W., Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000, 287:1497-1500.
20. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
21. Piskin G., Sylva-Steenland R.M., Bos J.D., Teunissen M.B. Invitro and insitu expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J.Immunol. 2006, 176:1908-1915.
22. Puig-Kröger A., Corbí A. RUNX3: a new player in myeloid gene expression and immune response. J.Cell. Biochem. 2006, 98:744-756.
23. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9:313-323.
24. Shibata W., Takaishi S., Muthupalani S., Pritchard D.M., Whary M.T., Rogers A.B., Fox J.G., Betz K.S., Kaestner K.H., Karin M., et al. Conditional deletion of IkappaB-kinase-beta accelerates helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia. Gastroenterology 2010, 138:1022-1034.e1-10.
25. Voon D.C., Wang H., Koo J.K., Nguyen T.A., Hor Y.T., Chu Y.S., Ito K., Fukamachi H., Chan S.L., Thiery J.P., Ito Y. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity. Stem Cells 2012, 30:2088-2099.
26. Watanabe K., Sugai M., Nambu Y., Osato M., Hayashi T., Kawaguchi M., Komori T., Ito Y., Shimizu A. Requirement for Runx proteins in IgA class switching acting downstream of TGF-beta 1 and retinoic acid signaling. J.Immunol. 2010, 184:2785-2792.
27. Zaph C., Troy A.E., Taylor B.C., Berman-Booty L.D., Guild K.J., Du Y., Yost E.A., Gruber A.D., May M.J., Greten F.R., et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 2007, 446:552-556.